Our mission at Core Prognostex, Inc. is to provide the cancer research and treatment communities with tools to uniformly obtain, collect, preserve, and ship high-quality tissue samples from commonly encountered human tumors in any clinical setting. In this endeavor, we support the objective of the National Cancer Institute Office of Biorepositories and Biospecimen Research (OBBR).
OBBR has published Best Practices which inform our product development activities. To meet the objectives outlined in our mission statement, we develop, market, and distribute biospecimen acquisition kits and protocols to surgeons, radiologists, oncologists, and researchers in both public and private sector healthcare, and biomedical research industries. We further aim to establish this protocol as the standard by which all cancer tissue and blood samples will be acquired for assay.